Recent publications

The role of epigenomics in personalized medicine.

Kronfol MM, Dozmorov MG, Huang R, Slattum PW, McClay JL.

Expert Review in Precision Medicine and Drug Development 2 (1): 33-45

Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b.

Enga R, Rice AC, Weller P, Subler M, Lee D, Hall CP, Windle JJ, Beardsley PM, van den Oord EJ, McClay JL.

Neuroscience Letters  641: 26-32 

Deep sequencing of three loci implicated in large-scale GWAS smoking meta-analyses.

Clark SL, McClay JL, Adkins DE, Aberg KA, Kumar G, Nerella S, Xie LY, Collins AL, Crowley JJ, Quakenbush C, Hillard C, Gao G, Peterson R, Copeland W, Silberg J, Maes H, Sullivan PF, Costello EJ, van den Oord EJ.

Nicotine & Tobacco Research 18 (5): 626-31

High density methylation QTL analysis in human blood via next-generation sequencing of the methylated genomic DNA fraction.

McClay JL, Shabalin AA, Dozmorov MG, Adkins DE, Kumar G, Nerella S, Clark SL, Bergen SE, Hultman CM, Magnusson PKE, Sullivan PF, Aberg KA, van den Oord EJ. 

Genome Biology  16 (1): 291.

Combined whole methylome and genome-wide association study implicates CNTN4 in alcohol use.

Clark SL, Aberg KA, Nerella S, Kumar G, McClay JL, Chen W, Xie LY, Harada A, Shabalin AA, Gao G, Bergen SE, Hultman CM, Magnusson PKE, Sullivan PF, van den Oord EJ.

Alcoholism: Clinical and Experimental Research  39 (8): 1396-1405.

Neurochemical metabolomics reveals disruption to sphingolipid metabolism following chronic haloperidol administration.

McClay JL, Vunck SA, Batman AM, Crowley JJ, Vann RE, Beardsley PM, van den Oord EJ.

Journal of Neuroimmune Pharmacology  10 (3): 425-434.

Refinement of schizophrenia GWAS loci using methylome-wide association data.

Kumar G, Clark SL, McClay JL, Shabalin AA, Adkins DE, Xie LY, Chan R,  Nerella S, Swedish Schizophrenia Consortium, Kim Y, Sullivan PF, Hultman CM, Magnusson PKE, Aberg KA, van den Oord EJ.

Human Genetics  134 (1): 77-87.